Skip to main content
Timothy Flanigan, MD, Infectious Disease, Providence, RI

Timothy P Flanigan MD

HIV/AIDS Medicine


Professor of Medicine, Brown University

Join to View Full Profile
  • 164 Summit AveFain Bldg., Suite EProvidence, RI 02906

  • Phone+1 401-793-2928

  • Fax+1 401-793-7401

Dr. Flanigan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1983 - 1986
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1983

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 1991 - 2026
  • MA State Medical License
    MA State Medical License 1991 - 2022
  • OH State Medical License
    OH State Medical License 1987 - 1994
  • PA State Medical License
    PA State Medical License 1985 - 1988
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2007-2014
  • Fellow (FACP) American College of Physicians, 1996
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Miriam Hospital Seeking Kids for Lyme Disease Vaccine Trial
    Miriam Hospital Seeking Kids for Lyme Disease Vaccine TrialMay 24th, 2021
  • Masses Following CDC Health Guidelines 'Extremely Safe' to Attend, Expert Says
    Masses Following CDC Health Guidelines 'Extremely Safe' to Attend, Expert SaysMarch 8th, 2021
  • Violence, HIV Risks, and Polysubstance Use Among HIV-Positive People Who Inject Drugs in Ukraine
    Violence, HIV Risks, and Polysubstance Use Among HIV-Positive People Who Inject Drugs in UkraineJanuary 1st, 2021
  • Join now to see all

Grant Support

  • Emerging Infectious Disease and HIV Scholars Program at Brown UniversityBROWN UNIVERSITY2018–2028
  • HIV and Other Infectious Consequences of Substance UseMIRIAM HOSPITAL2001–2028
  • Drug USER Resources CoreNational Institute On Drug Abuse2008–2011
  • The Brown Initiative In HIV And AIDS Clinical Research For Minority CommunitiesNational Institute Of Mental Health2008–2011
  • Planning Grant FO Rthe Borwn Institute For Clinical And Translational ScienceNational Center For Research Resources2006
  • Adult Therapeutic Clinical Trials Program For HIV/AIDSNational Institute Of Allergy And Infectious Diseases2000–2006
  • Directly Observed Therapy(Dot) For TB And HIV In KenyaFogarty International Center2003–2005
  • Neurocognitive Consequences Of HIV/AIDS In South IndiaNational Institute Of Mental Health2003–2004
  • Directly Observed Haart For Active Substance AbusersNational Institute On Drug Abuse2000–2003
  • Core--Drug USER ResourcesNational Institute On Drug Abuse2002
  • Core--Women And AIDSNational Institute Of Allergy And Infectious Diseases1998–2001
  • Viral Activation Transfusion StudyDivision Of Blood Diseases And Resources1995–2000
  • Induction Of Anti-Hiv IGA In Rectum And Cervix Of WomenNational Institute Of Allergy And Infectious Diseases1994–1997
  • Modulation Of In Vitro Cryptosporidium Parvum InfectionNational Institute Of Allergy And Infectious Diseases1991–1993

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: